Yes, HIPAA applies to face-to-face marketing as it allows providers to engage in this form of marketing without requiring prior consent.
HIPAA generally requires healthcare providers to obtain written consent from patients before using or disclosing their protected health information (PHI) for marketing purposes. There are, however, exceptions that allow for face-to-face interactions without prior consent. A journal article published in the Nebraska Law Review notes, “Remunerated marketing considered part of health care operations fell roughly within three categories: face-to-face communications, communications concerning products and services of ‘nominal value, and communications concerning’ health-related products and services.”
As part of remunerated marketing, providers can engage in direct, in-person marketing communications without needing to secure authorization from patients. This is permissible as long as the communications do not use PHI in a manner that would typically require authorization. The exception allows for personal interaction between doctor and patient. Promotional gifts of nominal value can also be distributed without requiring patient consent to support marketing efforts.
Exceptions to patient consent under HIPAA include disclosures for treatment, payment, and healthcare operations, as well as public health purposes and emergencies.
Consent refers to a patient’s agreement to allow for the use of their PHI. Authorization is a more formal process that requires explicit written permission.
Yes, providers can receive remunerations from pharmacies for certain activities as long as they comply with HIPAA and do not involve the improper use of PHI without consent.